You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Patent: 10,028,922


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,028,922
Title:Method for enhancing folding and transport of misfolded glucocerebrosidase
Abstract: Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof.
Inventor(s): Mahuran; Don J. (Toronto, CA), Tropak; Michael B. (Toronto, CA), Buttner; Justin D. (Rosehill, AU), Blanchard; Jan E. (St. Catherines, CA), Brown; Eric D. (Oakville, CA)
Assignee: The Hospital for Sick Children (Ontario, CA) McMaster University (Ontario, CA)
Application Number:15/223,312
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,028,922

Introduction

Understanding the nuances of a patent, particularly its claims and the broader patent landscape, is crucial for inventors, patent attorneys, and business strategists. This article will delve into a comprehensive and critical analysis of the claims and the patent landscape for United States Patent 10,028,922, focusing on key aspects such as subject matter eligibility, claim construction, and the impact of recent USPTO guidance.

Understanding the Patent

To begin with, it is essential to understand the core of the patent in question. While the specific details of US Patent 10,028,922 are not provided here, we can generalize the analysis based on common principles of patent law and recent updates.

Subject Matter Eligibility

Subject matter eligibility is a critical aspect of patent law, governed by 35 U.S.C. § 101. This section requires that a claimed invention must fall within one of the four statutory categories: processes, machines, manufactures, or compositions of matter. Additionally, the invention must not be directed to a judicial exception (e.g., abstract ideas, natural phenomena, or laws of nature) unless it integrates the exception into a practical application[4].

Judicial Exceptions and Practical Applications

The 2024 USPTO guidance update emphasizes the importance of evaluating whether a claim integrates a judicial exception into a practical application. For instance, if a claim involves an abstract idea, it must include additional elements that impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter. This is illustrated by the distinction between claims that merely use mathematical models to manipulate data and those that apply the data in a specific, practical manner[3].

Claim Construction

Claim construction is the process of determining the meaning and scope of the claims in a patent. This process is crucial for understanding what the patent covers and what it does not.

Independent and Dependent Claims

Patent claims can be independent or dependent. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim. The relationship between these claims is vital for understanding the scope of the patent[2].

The Role of Recent USPTO Guidance

The 2024 USPTO guidance update provides significant clarifications on several key issues.

Detailed Analysis of Abstract Ideas

The guidance enhances the focus on evaluating whether a claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, thereby transforming the claim into patent-eligible subject matter[3].

AI-Assisted Inventions

The update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This distinction is crucial as it ensures that AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution[3].

Patent Scope and Claims Data

The Patent Claims Research Dataset provided by the USPTO offers detailed insights into claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. This dataset can help in analyzing the scope of patents and understanding trends in claim construction and subject matter eligibility[2].

Double Patenting

Double patenting occurs when two patents are issued for the same invention to the same inventor or where there is a common inventor or applicant/assignee. This is prohibited under 35 U.S.C. § 101, and patent applicants must ensure that their claims do not overlap with previously granted patents[4].

Utility Requirement

A claimed invention must also meet the utility requirement, meaning it must be useful or have a specific, substantial, and credible utility. A rejection on the ground of lack of utility is appropriate if the applicant fails to identify any specific and substantial utility or if the asserted utility is not credible[4].

Searching and Analyzing Patents

To analyze the patent landscape, one must be proficient in searching for patents. The USPTO provides several tools, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources help in identifying prior art, understanding the patent family, and accessing file histories of related applications[5].

Real-World Applications and Practical Utility

Highlighting the real-world applications of the claimed method or system is crucial for demonstrating patent eligibility. For example, if a claim involves using separated audio components in a speech recognition system to enhance the accuracy of voice commands, it provides a practical application that transforms the abstract idea into patent-eligible subject matter[3].

Case Law and Precedents

Recent case law and precedents play a significant role in shaping the patent landscape. The 2024 USPTO guidance incorporates recent case law to provide clearer guidelines on subject matter eligibility and the integration of judicial exceptions into practical applications[3].

Key Takeaways

  • Subject Matter Eligibility: Ensure that the claimed invention integrates judicial exceptions into practical applications to meet the criteria for patent eligibility.
  • Claim Construction: Understand the relationship between independent and dependent claims to determine the scope of the patent.
  • AI-Assisted Inventions: Recognize that AI’s role as a tool does not impact subject matter eligibility, provided there is significant human contribution.
  • Utility Requirement: The invention must have a specific, substantial, and credible utility to avoid rejection.
  • Patent Searching: Utilize USPTO tools to identify prior art and understand the patent family.
  • Real-World Applications: Highlight practical applications to demonstrate patent eligibility.

FAQs

Q: What is the significance of subject matter eligibility in patent law? A: Subject matter eligibility ensures that a claimed invention falls within one of the four statutory categories and is not directed to a judicial exception unless it integrates the exception into a practical application.

Q: How does the 2024 USPTO guidance update impact AI-assisted inventions? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution.

Q: What is double patenting, and why is it prohibited? A: Double patenting occurs when two patents are issued for the same invention to the same inventor or where there is a common inventor or applicant/assignee. It is prohibited under 35 U.S.C. § 101 to prevent redundant patenting.

Q: How can one ensure that a claimed invention meets the utility requirement? A: The invention must have a specific, substantial, and credible utility. The applicant must identify and assert a utility that is well-established and credible.

Q: What tools does the USPTO provide for searching and analyzing patents? A: The USPTO provides tools such as the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) to help in searching for patents and analyzing the patent landscape.

Sources

  1. US10028937B2 - Anti-viral compounds - Google Patents
  2. Patent Claims Research Dataset - USPTO
  3. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  4. 2104-Requirements of 35 U.S.C. 101 - USPTO
  5. Search for patents - USPTO

More… ↓

⤷  Subscribe

Details for Patent 10,028,922

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genzyme Corporation CEREZYME imiglucerase For Injection 020367 May 23, 1994 ⤷  Subscribe 2027-09-17
Genzyme Corporation CEREZYME imiglucerase For Injection 020367 September 22, 1999 ⤷  Subscribe 2027-09-17
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.